Daniel Margolis, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Promaxo, Inc
    Topic:
    Prostate MRI
    Date added:
    06/03/2024
    Date updated:
    06/03/2024
    Relationship end date:
    03/25/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Guerbet, Inc
    Topic:
    Contrast Media
    Date added:
    06/03/2024
    Date updated:
    06/03/2024
    Relationship end date:
    06/06/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Stratagen Bio
    Topic:
    Quantitative MRI
    Date added:
    06/03/2024
    Date updated:
    06/03/2024
    Relationship end date:
    06/01/2026
Return to Sept. 27-28, 2024 - Symposium for Evolving Therapies and Drug Development in Oncology